Similarly, by the combination of UCA1 and PGM5-AS1, the AUC valued could be improved to 0.832 (95% CI: 0.782–0.882) for the early stage (stage I and II) CRC diagnosis (Figure 3B). This evidence concerns the gene PGM5 and colorectal carcinoma.